Home

Search

8 things to know about drug-resistant tuberculosis

by Sandeep Juneja, Senior Vice President, Market Access, TB Alliance

Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment

by MedAccess, Viatris and TB Alliance

Partners announce reduced price for patient-friendly tuberculosis preventive treatments

by MedAccess, Unitaid, CHAI and The Aurum Institute

“I know first-hand the importance of patient-friendly TB treatment”

by MedAccess

Improving availability of patient-friendly tuberculosis preventive therapy

by MedAccess

Our partners